Edesa Biotech, Inc.
Edesa Biotech, Inc. (EDSA) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · EDSA · as of Sep 30, 2025
Ownership Breakdown
23
Institutional Holders
▲ 3 vs Q2
$7.10M
Total Inst. Value
▲ $2.82M vs Q2
8.89M
Shares Outstanding
freeFloat 81.48%
2.88M
13F Shares Held
▲ 768,592 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
EDSA largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
RUBRIC CAPITAL MANAGEMENT LP pharmaceutical preparations | 687.5K | 9.79% | 9.79% | $1.70B | Nov 14, 2025 | — held |
VELAN CAPITAL INVESTMENT MANAGEMENT LP pharmaceutical preparations | 687.5K | 9.79% | 9.79% | $1.70B | Nov 14, 2025 | — held |
STONEPINE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 687.5K | 9.79% | 9.79% | $1.70B | Nov 13, 2025 | ▲ 687.5K |
NANTAHALA CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 625.0K | 8.90% | 8.90% | $1.54B | Nov 14, 2025 | — held |
VANGUARD GROUP INC pharmaceutical preparations | 45.5K | 64.85% | 64.85% | $111.13M | Nov 7, 2025 | ▲ 29.7K |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 45.2K | 64.41% | 64.41% | $110.38M | Nov 12, 2025 | ▲ 17.3K |
COMMONWEALTH EQUITY SERVICES, LLC pharmaceutical preparations | 37.5K | 53.47% | 53.47% | $93.00M | Oct 22, 2025 | ▲ 2.5K |
RENAISSANCE TECHNOLOGIES LLC pharmaceutical preparations | 25.0K | 35.60% | 35.60% | $61.75M | Nov 13, 2025 | NEW |
SUSQUEHANNA INTERNATIONAL GROUP, LLP pharmaceutical preparations | 14.6K | 20.80% | 20.80% | $35.65M | Nov 14, 2025 | NEW |
CITADEL ADVISORS LLC pharmaceutical preparations | 14.0K | 19.98% | 19.98% | $34.24M | Nov 14, 2025 | ▼ 9.5K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
5
Increased
+738.1K shares4
New Positions
first time holders3
Decreased
−10.5K shares2
Sold Out
fully exitedNet shares change (top 50)
+727.6K
+738.1K / −10.5K
Net new holders
+4
4 new / 2 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
EDSA insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
12
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Nijhawan Pardeep Chief Executive Officer | Jun 1, 2026 | Award | 1,671 | — | — | 731.1K | Form 4 ↗ |
Marshall Patrick director | May 27, 2026 | Award | 19,000 | — | — | 71.7K | Form 4 ↗ |
MacDonald Sean Arthur director | May 27, 2026 | Award | 19,000 | — | — | 41.1K | Form 4 ↗ |
Chypyha Joan director | May 27, 2026 | Award | 19,000 | — | — | 30.0K | Form 4 ↗ |
Weiler Peter J. Chief Financial Officer | May 27, 2026 | Award | 64,609 | — | — | 129.6K | Form 4 ↗ |
Brooks Michael J President | May 27, 2026 | Award | 64,609 | — | — | 291.5K | Form 4 ↗ |
Sistilli Carlo director | May 27, 2026 | Award | 19,000 | — | — | 49.4K | Form 4 ↗ |
Olson Charles V director | May 27, 2026 | Award | 19,000 | — | — | 30.0K | Form 4 ↗ |
Nijhawan Pardeep Chief Executive Officer | May 27, 2026 | Award | 96,913 | — | — | 729.5K | Form 4 ↗ |
Liu Da David director | May 27, 2026 | Award | 19,000 | — | — | 24.5K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Edesa Biotech, Inc. (EDSA) is primarily owned by institutional investors, who hold approximately 32.4% of total shares outstanding. Company insiders own approximately 18.52%, while retail and public investors account for the remaining 49.13%.
The largest institutional shareholder of Edesa Biotech, Inc. is RUBRIC CAPITAL MANAGEMENT LP, holding approximately 687,500 shares — equal to 9.79% of outstanding shares — as of September 30, 2025.
A total of 23 institutional investors currently hold EDSA stock, with a combined institutional value of approximately $7,101,619 as of the most recent 13F filing period.
Frequently asked questions
EDSA ownershipEdesa Biotech, Inc. (EDSA) is primarily owned by institutional investors, who hold approximately 32.4% of shares. The largest shareholder is RUBRIC CAPITAL MANAGEMENT LP with a 9.79% stake. Company insiders hold 18.52%. Data sourced from SEC Form 13F as of September 30, 2025.